Development of new antituberculosis drugs

Preface Global Control of Tuberculosis and New Drugs -- Public health aspects of new drug development for tuberculosis Genomics in the Fight Against Mycobacterial Diseases Target Selection to Shorten the Course of Tuberculosis Chemotherapy Pharmacological Issues in the Development of New Antituberculosis Drugs The Mouse Model in Evaluation of New Antituberculosis Drugs: Promise And Limitations Surrogate Markers to Assess Clinical Efficacy of New Antituberculosis Drugs Early Bactericidal Activity Studies: Promise and Pitfalls Role of Clinical Trials in the Evaluation of New Anti-Tuberculosis Drugs Current and Future Uses of Rifamycins in the Treatment of Pulmonary Tuberculosis Fluoroquinolones in the Treatment of Tuberculosis: Current Status and Future Issues Management of Latent Tuberculosis Infection Today and in the Future Novel Delivery Systems for Antituberculosis Drugs Immunology of Tuberculosis: Implications for the Development of New Therapies and Vaccines Index.